酮咯酸氨丁三醇复合舒芬太尼对骨科手术患儿术后镇痛的临床效果

摘要
图/表
参考文献(15)
相关文章 (15)

全文: PDF (424 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨酮咯酸氨丁三醇复合舒芬太尼对骨科手术患儿术后镇痛的临床效果。方法选取2017年4月至2019年4月赣州市中医院收治的60 例全麻下行骨折复位手术患儿为研究对象。采用随机数字表法分为观察组和对照组，每组30 例。对照组使用舒芬太尼进行镇痛，观察组采用酮咯酸氨丁三醇复合舒芬太尼进行镇痛。比较两组不同时间点舒芬太尼剂量、镇痛泵按压次数、CRIES 评分、5-羟色胺（5-HT）水平、P 物质（PS）水平及不良反应发生情况。结果两组组内术后4、8、24 h 的舒芬太尼剂量呈递增趋势，术后4、8 h 镇痛泵按压次数多于术后1 h，术后24 h 镇痛泵按压次数少于术后1、4、8 h，差异有统计学意义（P＜0.05）；观察组术后1、4、8、24 h 的舒芬太尼剂量和按压次数均低于对照组，差异有统计学意义（P＜0.05）。两组组内术后4、8、24 h 的CRIES 评分呈递减趋势，两组术后1 h CRIES 评分比较，差异无统计学意义（P＞0.05），观察组术后4、8、24 h 的CRIES 评分低于对照组，差异有统计学意义（P＜0.05）。两组术后2 d 的5-HT、PS 水平均高于术后1 d，术后3 d 高于术后1、2 d，差异有统计学意义（P＜0.05）；观察组术后1、2、3 d 的5-HT、PS 水平均低于对照组，差异有统计学意义（P＜0.05）。两组术后不良反应总发生率比较，差异无统计学意义（P＞0.05）。结论酮咯酸氨丁三醇复合舒芬太尼用于患儿骨科手术，镇痛效果好，抑制5-HT、PS 浓度的升高，安全性高。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	赖建鸿
	曾凡英
	龙燕

关键词 ：骨科手术, 酮咯酸氨丁三醇, 舒芬太尼, 五羟色胺, P 物质

Abstract：Objective To investigate the clinical effect of Ketorolac Traminotriol combined with Sufentanil on postoperative analgesia in children undergoing orthopedic surgery. Methods A total of 60 children undergoing fracture reduction under general anesthesia in Ganzhou Hospital of Traditional Chinese Medicine from April 2017 to April 2019 were selected as the research objects. The patients were divided into observation group and control group by random number table method, 30 cases in each group. The control group was treated with Sufentanil for analgesia, and the observation group was treated with Ketorolac Traminotriol combined with Sufentanil for analgesia. Sufentanil dosage, press times,CRIES score, 5-hydroxytryptamine (5-HT) level, substance P (PS) level and adverse reactions were compared between the two groups at different time points. Results The dose of Sufentanil at 4, 8 and 24 h after operation showed an increasing trend in both groups, the number of analgesic pump compressions at 4 and 8 h after surgery was more than 1 h after surgery, and the number of analgesic pump compressions at 24 h after surgery was less than 1, 4 and 8 h after surgery, the differences were statistically significant (P<0.05). The dose and pressing times of Sufentanil in the observation group were lower than those in the control group at 1, 4, 8 and 24 h after operation, the differences were statistically significant (P<0.05). At 4, 8 and 24 h after surgery, the scores of the two groups decreased. There was no significant difference between the two groups at 1 h after surgery (P>0.05). The CRIES of the observation group were lower than those of the control group at 4, 8 and 24 h after surgery, the differences were statistically significant (P<0.05). The levels of 5-HT and PS in both groups were higher on postoperative day 2 than postoperative day 1, and higher on postoperative day 3 than postoperative day 1 and 2, the differences were statistically significant (P<0.05). The levels of 5-HT and PS in the observation group were lower than those in the control group on day 1, 2 and 3 after operation, the differences were statistically significant (P<0.05). There was no significant difference in the total incidence of postoperative adverse reactions between the two groups(P>0.05). Conclusion Ketorolac Tromethamine combined with Sufentanil for pediatric orthopedic surgery has good analgesic effect, inhibits the increase of 5-HT and PS concentration, and has high safety.

Key words： Orthopedic surgery Ketorolac Tromethamine Sufentanil Serotonin Substance P

基金资助:江西省卫生健康委科技计划项目（20204638）；江西省赣州市指导性科技计划任务（GZ2017ZSF306）

引用本文:

赖建鸿；曾凡英；龙燕. 酮咯酸氨丁三醇复合舒芬太尼对骨科手术患儿术后镇痛的临床效果[J]. 中国当代医药, 2022, 29(8): 118-121.
LAI Jianhong；ZENG Fanying；LONG Yan. Clinical effect of Ketorolac Traminotriol combined with Sufentanil on postoperative analgesia in children undergoing orthopedic surgery. 中国当代医药, 2022, 29(8): 118-121.

链接本文:

https://www.dangdaiyiyao.com/CN/ 或 https://www.dangdaiyiyao.com/CN/Y2022/V29/I8/118

[1]	Mahikhan F，Hashemian M，Dehesh T，et al.Impact of ondansetron on withdrawal signs，fentanyl requirement and pain relief in opioid addicted patients under general anesthesia[J].Curr Clin Pharmacol，2019，14（3）：232-241.
[2]	Soffin EM，Waldman SA，Stack RJ，et al.An Evidence -Based Approach to the Prescription Opioid Epidemic in Orthopedic Surgery[J].Anesth Analg，2017，125（5）：1704-1713.
[3]	李玲芳，许丽琴.超声波理疗在儿童创伤骨科术后疼痛管理中的效果[J].浙江医学，2020，42（7）：744-746.
[4]	郝海宁，薛行行，王丽，等.舒芬太尼联合依托咪酯对老年骨科手术患者应激反应及术后情况的影响[J].医学临床研究，2017，34（11）：2238-2240.
[5]	Na OY，Nam KK，Ae JM，et al.Effects of nefopam with fentanyl in intravenous patient -controlled analgesia after arthroscopic orthopedic surgery：a prospective double-blind randomized trial[J].Turk J Med Sci，2018，48（1）：142-149.
[6]	夏敏，周旺辉，王凌.右美托咪定联合氢吗啡酮在脑瘫儿术后静脉自控镇痛中的运用价值[J].四川医学，2018，39（10）：1159-1162.
[7]	陈彩艳，楼洁，邵瑾.氢吗啡酮复合舒芬太尼在骨科手术后静脉自控镇痛中的效果及安全性[J].临床骨科杂志，2017，20（4）：463-465.
[8]	郝海宁，薛行行，王丽，等.舒芬太尼联合依托咪酯对老年骨科手术患者应激反应及术后情况的影响[J].医学临床研究，2017，34（11）：2238-2240.
[9]	孙震，王琦，吕晶，等.骨科手术中芬太尼诱发患儿咳嗽与术后恶心呕吐的相关性[J].临床麻醉学杂志，2018，34（2）：137-139.
[10]	杨柳，王竹，姚少红，等.罗哌卡因复合舒芬太尼臂丛神经阻滞在上肢手术患儿中的应用效果[J].中国当代医药，2021，28（8）：144-146，150.
[11]	李海燕，郑智文，杨兴，等.盐酸右美托咪定联合瑞芬太尼在骨科手术中的镇静效果及对患者血流动力学和呼吸功能的影响[J].现代生物医学进展，2018，18（3）：532-536.
[12]	罗瑞，郭宇峰，张利佳，等.舒芬太尼联合酮咯酸氨丁三醇超前镇痛用于骨科患者术后镇痛中的价值分析[J].山西医药杂志，2020，49（1）：36-37.
[13]	邹雨霞，张兆伟，秦妮娜.酮咯酸氨丁三醇复合地佐辛用于腹腔镜卵巢囊肿剔除术超前镇痛效果及对血清5 羟色胺和P 物质影响[J].临床误诊误治，2018，31（2）：69-72.
[14]	马爱兵，冯涛，曹新萍.酮咯酸氨丁三醇联合舒芬太尼在腹腔镜胆囊切除术静脉自控镇痛中的临床应用[J].腹腔镜外科杂志，2019，24（11）：855-858.
[15]	刘丽，王中林，彭明清.酮咯酸氨丁三醇超前镇痛对儿童下腹腔镜手术应激反应的影响[J].儿科药学杂志，2017，23（3）：25-27.